[ad_1]
Rome, September 4, 2020 – Le mass vaccinations With the’anti-Covid “Realistically, they won’t be there before mid-2021.” This was stated by Margaret Harris, spokesperson for theWorld Health Organization, speaking to journalists in Geneva. Harris specified that “six of the nine candidate vaccines are in advanced stages of testing, some in phase 3 clinical trials.” But this step 3 it takes longer, because we need to see how protective the vaccine really is and how safe it is, ”Harris explained, referring to ongoing clinical trials.
Coronavirus Italy, the newsletter of September 4
Coronavirus, Iss index: Rt at 1.18, widespread transmission. Symptoms increase
Russian Sputnik vaccine
Meanwhile, the first data on the Russian Sputnik vaccine anti-Covid. According to reports from Denis Logunov’s group, from the Gamaleya National Institute of Epidemiological Research in Moscow, the vaccine would have produced an immune response in the 76 volunteers, healthy adults between 18 and 60 years old, involved in phases 1 and 2 of the trial. . The results, referring to two studies carried out between June 18 and August 3, show that the 100% of the participants developed antibodies against the SarsCov2 virus, without having serious side effects.
Coronavirus world, latest updates
Sovereign Cuban vaccine 01
The leaders of the Finlay Vaccine Institute in Cuba have presented to the WHO the advances that highlight the Cuban vaccine that is being tested for Covid-19, ‘Sovereign 01‘. In a virtual meeting held at the WHO headquarters in Havana, in fact, experts and researchers discussed phase I and II clinical trials, which aim to demonstrate thevaccine efficacy, which has been applied since last August 24 to Cuban volunteers, a first group of 20 units aged between 19 and 59 years, to which a second group is now added, the same as between 60 and 80 years old. The members of the first vaccinated group, claims Prensa Latina on the basis of generalized reports, are in good health.
‘Soberana 01’ is an adaptive, multicenter, controlled and randomized clinical trial, in which the 40 volunteers receive the vaccine with an injection in its two variants, a lower dose and a higher dose. Once phase I is completed, the investigational vaccine, which is one of 30 that has received authorization from the WHO for testing in humans, will move to the next phase on September 11, with the expansion of the sample of volunteers to 676, including 40 of the first phase. The research in all its phases should be completed in January 2021 and the vaccine could be available to the population in February.
Aifa: “Anticipating Flu Vaccination in October”
“It is recommended to anticipate conducting campaigns for flu vaccine Starting sincebeginning of October and offer vaccination to eligible subjects at any time during the influenza season, even if they are late for vaccination. “This was stated by the Italian Medicines Agency (Aifa) in the publication in the Official Gazette, which authorizes the update of the composition of influenza vaccines for the 2020-2021 season, in accordance with the recommendations of the World Health Organization (WHO) and the European Medicines Agency (Ema).
© All rights reserved
